The future of blood substitutes looks promising with ongoing research and development. Advances in biotechnology and materials science are driving the creation of more effective and safer substitutes. Innovations such as genetically engineered hemoglobin and nanotechnology-based carriers hold potential for revolutionizing the field. Additionally, interdisciplinary collaboration among scientists, healthcare providers, and policymakers will be essential for translating these innovations into practical solutions.
